Argent Advisors’s BioTelemetry, Inc. BEAT Stock Holding History

Argent Advisors’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-5	Closed	–	–	585
2019 Q4	$0	Buy	+5	New	+$217	﹤0.01%	585

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Argent Advisors's BEAT Position: Q1 2020 in Review

Argent Advisors sold out of BioTelemetry, Inc. (BEAT) in Q1 2020, closing a stake of 5 shares.

Argent Advisors first reported a position in BEAT in Q4 2019 and held it in 1 quarter. The position peaked at $0 in Q4 2019. 209 funds tracked by Wall St. Rank hold BEAT as of Q1 2020.

Argent Advisors reported no remaining BioTelemetry, Inc. position as of Q1 2020 after selling out during the quarter.
Argent Advisors sold 5 BioTelemetry, Inc. shares in Q1 2020.
Argent Advisors first reported a position in BioTelemetry, Inc. in Q4 2019 and held it in 1 quarter.
Argent Advisors's BioTelemetry, Inc. position peaked at $0 in Q4 2019.
209 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2020.

Based on Argent Advisors's 13F filing for Q1 2020, filed 23 Apr 2020.